Suppliers / Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine

China Updated 9 July 2026

The public registers hold a second record for Jiangsu Hengrui Medicine. The fuller profile, with 21 active US DMFs and 6 valid CEPs, is at Jiangsu Hengrui. Figures on this page cover only this record.

Jiangsu Hengrui Medicine is an API manufacturer based in China. It appears in 13 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and EDA (EG).

0
active US DMFs
0
valid CEPs
1
registered plants
13
filings across 5 regulators

Registered plants

Site FDA FEI
Lianyungang, China Not on file

What they file, and where

Molecule Regulators Docs
Atracurium Besylate SFDA (Saudi Arabia) 1
Cisatracurium SFDA (Saudi Arabia) 1
Docetaxel SFDA (Saudi Arabia) 1
Ifosfamide SFDA (Saudi Arabia) 1
Oxaliplatin SFDA (Saudi Arabia) 1
Sevoflurane SFDA (Saudi Arabia) 1
Tolvaptan SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Atracurium API Cisatracurium API Ifosfamide API Oxaliplatin API Sevoflurane API Tolvaptan API Docetaxel API

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 5 None
MINSA (CR) 4 None
EDA (EG) 2 None
INVIMA (CO) 1 None
UZPHARM (UZ) 1 None

Questions about Jiangsu Hengrui Medicine

Does Jiangsu Hengrui Medicine hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Jiangsu Hengrui Medicine. It does have 13 filings with 5 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Jiangsu Hengrui Medicine manufacture?
1 registered site is on record, in China (Lianyungang). Every site is listed on this page with the register it came from.
What does Jiangsu Hengrui Medicine make?
7 molecules are on record against Jiangsu Hengrui Medicine, including Atracurium Besylate, Cisatracurium, Docetaxel and Ifosfamide. Each links through to that molecule's full manufacturer list.
Where does Jiangsu Hengrui Medicine file?
Filings are on record with ARCSA (EC), MINSA (CR), EDA (EG), INVIMA (CO) and 1 other regulator, 13 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Hengrui Medicine comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Gland Pharma shares 2 molecules Farmhispania shares 2 molecules CF Pharma shares 2 molecules Lianyungang Guike Pharmaceutical shares 2 molecules Wavelength Enterprises shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability